BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 5622482)

  • 1. Some observations on the site of action of oxypertin.
    Fuxe K; Grobecker H; Hökfelt T; Jonsson J; Malmfors T
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 256(4):450-63. PubMed ID: 5622482
    [No Abstract]   [Full Text] [Related]  

  • 2. [Differential depletion of storage sites for noradrenalin, dopamine and serotonin by oxypertin].
    Hassler R; Bak IJ; Kim JS
    Nervenarzt; 1970 Mar; 41(3):105-18. PubMed ID: 5447883
    [No Abstract]   [Full Text] [Related]  

  • 3. Histochemical studies on the distribution of catecholamines and 5-hydroxytryptamine after intraventricular injections.
    Fuxe K; Ungerstedt U
    Histochemie; 1968; 13(1):16-28. PubMed ID: 5741831
    [No Abstract]   [Full Text] [Related]  

  • 4. The influence of benzquinamide, oxypertine and prenylamine on monoamine levels and on monoamine effects in the spinal cord.
    Andén NE; Fuxe K
    Acta Pharmacol Toxicol (Copenh); 1971; 30(3):225-37. PubMed ID: 4333577
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on central and peripheral noradrenaline neurons using a new dopamine-(beta)-hydroxylase inhibitor.
    Corrodi H; Fuxe K; Hamberger B; Ljungdahl A
    Eur J Pharmacol; 1970 Oct; 12(2):145-55. PubMed ID: 5472868
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential monoamine depletion by oxypertine in nerve terminals. Granulated synaptic vesicles in relation to depletion of norepinephrine, dopamine and serotonin.
    Bak IJ; Hassler R; Kim JS
    Z Zellforsch Mikrosk Anat; 1969; 101(3):448-62. PubMed ID: 5362847
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuronal localization of monoamines in the cerebral ganglia of the snail Helix pomatia.
    Bardessono F; Glacobini E; Stepita-Klauco M
    Brain Res; 1972 Dec; 47(2):427-37. PubMed ID: 4264629
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of dopamine, noradrenaline and 5-hydroxytryptamine varicosities in a fraction containing nerve ending particles.
    Fuxe K; Grobecker H; Hökfelt T; Jonsson G
    Brain Res; 1967 Nov; 6(3):475-80. PubMed ID: 6076252
    [No Abstract]   [Full Text] [Related]  

  • 9. Receptor activity and turnover of dopamine and noradrenaline after neuroleptics.
    Andén NE; Butcher SG; Corrodi H; Fuxe K; Ungerstedt U
    Eur J Pharmacol; 1970; 11(3):303-14. PubMed ID: 5477307
    [No Abstract]   [Full Text] [Related]  

  • 10. Histological and molecular biochemistry.
    Andén NE; Bartholini G; Corrodi H; Csillik B; De Robertis E; Dresse A; Fuxe K; Gerebtzoff MA; Glowinski J; Hansson E; Hökfelt T; Renson J; Roos BE
    Mod Probl Pharmacopsychiatry; 1970; 5():1-11. PubMed ID: 4348145
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of dopalanine on behaviour in mice depleted of norepinephrine or serotonin.
    Chruściel TL; Herman ZS
    Psychopharmacologia; 1969; 14(2):124-34. PubMed ID: 5350621
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparison between the effect of L-dopa and its methylated ester on cerebral dopamine and noradrenaline of rats exposed to oxypertin].
    Van den Driessche J; Sado M; Linée P; Lacroix P; Le Clec'h G; Delamaire J; Patay M
    C R Seances Soc Biol Fil; 1973; 167(5):754-9. PubMed ID: 4799139
    [No Abstract]   [Full Text] [Related]  

  • 13. Kinetics of serotonin accumulation into slices from rat brain: relationship to catecholamine uptake.
    Shaskan EG; Snyder SH
    J Pharmacol Exp Ther; 1970 Nov; 175(2):404-18. PubMed ID: 5481708
    [No Abstract]   [Full Text] [Related]  

  • 14. Importance of nervous impulse flow for the neuroleptic induced increase in amine turnover in central dopamine neurons.
    Andén NE; Corrodi H; Fuxe K; Ungerstedt U
    Eur J Pharmacol; 1971 Jul; 15(2):193-9. PubMed ID: 4341651
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the uptake and accumulation of 3H-noradrenaline in adenergic nerves after pretreatment with reserpine, nialamide and a tyrosine-hydroxylase inhibitor.
    Hamberger B; Jonsson G; Almfors T; Sachs C
    Br J Pharmacol; 1968 Sep; 34(1):225P-226P. PubMed ID: 5676027
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of the behavioral depressant effects of biogenic amine depleting and neuroleptic agents following various 6-hydroxydopamine treatments.
    Cooper BR; Grant LD; Breese GR
    Psychopharmacologia; 1973 Jul; 31(2):95-109. PubMed ID: 4722209
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on uptake of intraventricularly administered tritiated noradrenaline and 5-hydoxytryptamine with combined fluorescence histochemical and autoradiographic technics.
    Fuxe K; Hökfelt T; Ritzén M; Ungerstedt U
    Histochemie; 1968; 16(2):186-94. PubMed ID: 5710413
    [No Abstract]   [Full Text] [Related]  

  • 18. Minor tranquillizers, stress and central catecholamine neurons.
    Corrodi H; Fuxe K; Lidbrink P; Olson L
    Brain Res; 1971 Jun; 29(1):1-16. PubMed ID: 5564261
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of neuroleptic drugs on central catecholamine turnover assessed using tyrosine- and dopamine- -hydroxylase inhibitors.
    Andén NE; Corrodi H; Fuxe K
    J Pharm Pharmacol; 1972 Mar; 24(3):177-82. PubMed ID: 4402775
    [No Abstract]   [Full Text] [Related]  

  • 20. A reliable method for the simultaneous estimation of dopamine, noradrenaline and serotonin in discrete areas of brain.
    Butterworth RF; Landreville F; Guitard M; Barbeau A
    Clin Biochem; 1975 Oct; 8(5):298-302. PubMed ID: 1201621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.